Toll like receptors, recognize bacterial products and stimulates immune response by –
So the core concept here is that TLRs are pattern recognition receptors (PRRs) that detect PAMPs. When they bind to these PAMPs, they trigger signaling pathways that lead to the production of cytokines and other immune responses. The key here is the signaling pathway involved after TLR activation.
The correct answer is likely related to the MyD88-dependent pathway. I remember that MyD88 is an adapter protein involved in TLR signaling. When TLRs bind to their ligands, they recruit MyD88, which then activates IRAK kinases. This leads to the activation of NF-κB, which is a transcription factor that promotes the expression of pro-inflammatory cytokines and other immune mediators.
Now, looking at the wrong options: some might suggest other pathways like JAK-STAT, which is more involved in cytokine signaling. Others might mention the inflammasome, which is a separate component of the innate immune system. There's also the possibility of options related to the complement system or phagocytosis, but those are different mechanisms.
The clinical pearl here is that TLRs are crucial for the innate immune response's first line of defense. Understanding their signaling pathways is important because they're targets for immunotherapies and vaccines. Also, the MyD88 pathway is a key point in exams, so students should remember that TLRs use MyD88 and NF-κB activation.
**Core Concept**
Toll-like receptors (TLRs) are pattern recognition receptors (PRRs) that detect pathogen-associated molecular patterns (PAMPs) from bacteria, such as lipopolysaccharides (LPS) or flagellin. Activation of TLRs initiates innate immune signaling via adapter proteins like **MyD88**, leading to NF-κB activation and cytokine production.
**Why the Correct Answer is Right**
TLRs recognize bacterial products through specific ligand binding (e.g., TLR4 for LPS). This triggers recruitment of the **MyD88 adapter protein**, which activates IRAK kinases and ultimately **NF-κB**. NF-κB translocates to the nucleus, inducing pro-inflammatory cytokines (e.g., TNF-α, IL-6), chemokines, and type I interferons. This pathway is critical for innate immunity and bridging adaptive immune responses.
**Why Each Wrong Option is Incorrect**
**Option A:** *JAK-STAT pathway* is activated by cytokine receptors (e.g., IFN-γ), not TLRs.
**Option B:** *Complement system* is a separate innate defense mechanism; TLRs do not directly activate it.
**Option C:** *Inflammasome activation* involves NLRP3 and caspase-1, distinct from TLR signaling pathways.
**Clinical Pearl / High-Yield Fact**
Memorize: **TLR → MyD88 → NF-κB